Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Magnesium Deficiency and Ventricular Tachycardia

Introduction to Magnesium and Ventricular Tachycardia

  • The American Heart Association recognizes the association between hypomagnesemia and ventricular tachycardia, particularly polymorphic VT and torsades de pointes, with a Class I recommendation for immediate magnesium administration (1-2 g IV push) in these life-threatening arrhythmias 1, 2
  • The European Society of Cardiology provides a Class I recommendation for correcting hypomagnesemia with magnesium salts when treating ventricular arrhythmias secondary to low magnesium, particularly in patients with structurally normal hearts 3

Mechanism and Clinical Association

  • Hypomagnesemia destabilizes cardiac myocyte membranes by disrupting calcium and potassium channel function, which predisposes to ventricular arrhythmias including premature ventricular contractions (PVCs), polymorphic VT, and torsades de pointes 3
  • Magnesium is essential for the movement of sodium, potassium, and calcium into and out of cells and plays a critical role in stabilizing excitable membranes 1
  • The strongest evidence links hypomagnesemia to polymorphic ventricular tachycardia (including torsades de pointes), which is a pulseless form of VT 1, 2

Clinical Evidence and Prognosis

  • Low plasma magnesium concentration is associated with poor prognosis in cardiac arrest patients 1, 2

High-Risk Populations Requiring Monitoring

  • Check magnesium levels in patients with malnutrition or chronic diarrhea 1
  • Check magnesium levels in patients with alcohol use disorder 2

Treatment Algorithm

  • Administer 1-2 g magnesium sulfate IV push immediately (Class I, Level of Evidence C) for life-threatening VT/cardiac arrest, particularly polymorphic VT and torsades de pointes 1, 2, 3
  • Target serum magnesium ≥2.0 mEq/L (approximately 0.82 mmol/L) for non-emergent ventricular arrhythmias with documented hypomagnesemia 3
  • Always check and correct both magnesium AND potassium simultaneously, as hypomagnesemia commonly coexists with hypokalemia and hypocalcemia 3
  • Correcting magnesium is essential for successful potassium repletion 3

Safety Monitoring

  • Monitor for magnesium toxicity, especially in patients with renal impairment 3, 4
  • Administer IV calcium (calcium chloride 10% 5-10 mL or calcium gluconate 10% 15-30 mL) as a physiological antagonist if magnesium toxicity occurs (Class IIb, LOE C) 1, 4